Stock 1548 GENSCRIPT BIOTECH CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Genscript Biotech Corporation

Equities

1548

KYG3825B1059

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:15 2024-04-18 am EDT 		5-day change 1st Jan Change
11.46 HKD -0.35% Intraday chart for Genscript Biotech Corporation -9.76% -42.30%
Apr. 17 Genscript Biotech's Unit Logs $157 Million in Q1 Sales of Blood Cancer Drug MT
Apr. 12 Genscript Biotech Corporation Announces Directorate Appointments and Change in Composition of Board Committee CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Genscript Biotech's Unit Logs $157 Million in Q1 Sales of Blood Cancer Drug
MT
GenScript Biotech officially joins SBTi to fulfill its sustainability commitment
AQ
Genscript Biotech Corporation Announces Directorate Appointments and Change in Composition of Board Committee
CI
Genscript Biotech Unit's Refractory Multiple Myeloma Drug Gets FDA Approval
MT
GenScript Biotech Receives EcoVadis Bronze Medal for Outstanding Sustainability Performance
AQ
Genscript Biotech's US Unit Secures FDA Nod for Anti-Cancer Medication
MT
Genscript Biotech Issues 444,598 Shares to Three Grantees Under Restricted Share Scheme
MT
Genscript Biotech's 2023 Loss Widens; Misses Revenue Estimates
MT
Transcript : Genscript Biotech Corporation, 2023 Earnings Call, Mar 11, 2024
Genscript Biotech Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Genscript Announces Appointment of Dr. David R. Liu to the Scientific Advisory Board
CI
Immunotherapy Pioneer Carl H. June, MD, Joins GenScript's Scientific Advisory Board to Guide Company's Innovation Strategy in Advancing Cell and Gene Therapy Breakthroughs
PR
GenScript Biotech Corporation Expands Collaboration with Roche
CI
GenScript Announces Its Inaugural Life Science Research Grant Project
PR
Genscript Biotech Unit Rakes in $159 Million in Sales for Myeloma Treatment; Shares Rise 4%
MT
Genscript Biotech Unit to Submit More Data to European, US Authorities for Approval of Myeloma Drug
MT
San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry
PR
Genscript, Legend Biotech On-Track to Begin Production at Ghent Facilities This Year
MT
Genscript Biotech's Subsidiary Legend Closes License Agreement with Novartis for Anti-Cancer Drug
MT
GenScript, GenScript ProBio, and Legend Biotech Will Attend the 42nd JPM Healthcare Conference, Advancing Innovation and Development in the Healthcare Sector
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1548 Stock
  4. News Genscript Biotech Corporation